These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2937371)

  • 1. Growth and somatomedin responses to growth hormone in Down's syndrome.
    Annerén G; Sara VR; Hall K; Tuvemo T
    Arch Dis Child; 1986 Jan; 61(1):48-52. PubMed ID: 2937371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development.
    Annerén G; Tuvemo T; Carlsson-Skwirut C; Lönnerholm T; Bang P; Sara VR; Gustafsson J
    Arch Dis Child; 1999 Apr; 80(4):334-8. PubMed ID: 10086938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency.
    Schalch DS; Tollefsen SE; Klingensmith GJ; Gotlin RW; Diehl MJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):49-55. PubMed ID: 6176592
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels.
    Albertsson-Wikland K; Hall K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):671-8. PubMed ID: 3654912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP; Van Meter QL; Kowarski AA
    Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins.
    Ranke MB; Blum WF; Bierich JR
    Acta Paediatr Scand Suppl; 1988; 347():114-26. PubMed ID: 2473597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone.
    Annerén G; Gustavson KH; Sara VR; Tuvemo T
    Am J Med Genet Suppl; 1990; 7():59-62. PubMed ID: 1963538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in specific binding of insulin-like growth factor (IGF) II to type 1 IGF receptors on erythrocytes of hypopituitary children receiving growth hormone therapy.
    Costigan CD; Polychronakos C; Guyda HJ; Posner BI
    Clin Invest Med; 1988 Feb; 11(1):47-51. PubMed ID: 2966692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factors I and II in evaluation of growth retardation.
    Rosenfeld RG; Wilson DM; Lee PD; Hintz RL
    J Pediatr; 1986 Sep; 109(3):428-33. PubMed ID: 3746530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children with normal-variant short stature: treatment with human growth hormone for six months.
    Rudman D; Kutner MH; Blackston RD; Cushman RA; Bain RP; Patterson JH
    N Engl J Med; 1981 Jul; 305(3):123-31. PubMed ID: 7195462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.
    Soliman AT; Hassan AE; Aref MK; Hintz RL; Rosenfeld RG; Rogol AD
    Pediatr Res; 1986 Nov; 20(11):1122-30. PubMed ID: 3099250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.
    Bright GM; Rogol AD; Johanson AJ; Blizzard RM
    Pediatrics; 1983 Apr; 71(4):576-80. PubMed ID: 6340044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, somatomedin levels and growth regulation in Turner's syndrome.
    Ranke MB; Blum WF; Haug F; Rosendahl W; Attanasio A; Enders H; Gupta D; Bierich JR
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):305-13. PubMed ID: 3687318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
    Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome.
    Barreca A; Rasore Quartino A; Acutis MS; Ponzani P; Damonte G; Miani E; Balestra V; Giordano G; Minuto F
    J Endocrinol Invest; 1994 Jun; 17(6):431-6. PubMed ID: 7930388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of insulin-like growth factor I: clinical applications and significance.
    Teale JD; Marks V
    Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of insulin-like growth factor assays.
    Lee PD; Rosenfeld RG
    Pediatrician; 1987; 14(3):154-61. PubMed ID: 3331010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease.
    Tönshoff B; Mehis O; Heinrich U; Blum WF; Ranke MB; Schauer A
    J Pediatr; 1990 Apr; 116(4):561-6. PubMed ID: 2319402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.